Pharmaceutical Manufacturers Editing and Proofreading Services

A batch fails a test. What happens next is not primarily a laboratory question — it is a writing question, because the investigation that follows will be read by an inspector three years later and judged on whether it found the cause or found a reason. The industry has a name for the second kind: the deviation that concludes "operator error, retraining provided", which appears in files everywhere and explains nothing.

We edit what pharmaceutical manufacturers produce — deviation and non-conformance investigations, out-of-specification investigation reports, batch manufacturing and packaging record instructions, corrective and preventive action documentation, change control documentation, standard operating procedures and work instructions, annual product quality reviews, validation protocols and reports, audit and inspection responses, complaint investigations, and technical agreements with contract manufacturers. Our editors work on the investigation record an inspector will read.

The deviation investigation is where a quality system either learns or accumulates paperwork, and its failure is stopping at the person. We work through these so the description states what actually happened before any interpretation, with the times, the equipment, the batch and who was present, since a description written after the conclusion tends to contain only the facts that support it; so the investigation records what was checked and eliminated as well as what was found, because an inspector's confidence comes from seeing the paths that were closed; so any human action is followed by the question of why the system permitted it — whether the procedure was ambiguous, the two steps looked identical, the setting could be entered without confirmation — as this is where the real cause almost always sits; so retraining appears only alongside a change to something else, given that retraining as a sole action is the single most recognisable weak investigation; so the impact assessment covers other batches, other products and other lines explicitly rather than concluding no impact, since extent of condition is where inspectors probe hardest; so the effectiveness check for each action is defined with what will be measured and when; and so anything unresolved is stated as unresolved rather than closed with a probable cause. Investigations written this way stand up years later.

Everything you send is treated in confidence, including batch records, investigations and inspection correspondence. We are editors rather than quality, manufacturing or regulatory specialists, and we offer no view on root cause, product impact or compliance. What we can do is make the record show the thinking rather than the conclusion.